University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Levofloxacin

Eye drops - high relative cost - second line. Use SDU if using one or two hourly, or if significant OSD/toxicity.

Status: Amber Levofloxacin (SDU)
Status: Amber Levomepromazine injection

Consultant initiation only

Status: Amber Levomepromazine tablets (Nozinan®)

Consultant initiation only, ESCA

Status: Amber Lidocaine 5% patch

For patients who have been treated in line with NICE CG173 Neuropathic pain in adults: pharmacological management in non-specialist settings but are still experiencing neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia)

Status: Amber Lignocaine 5% medicated plasters (30 plasters)

RICaD

Status: Amber Linaclotide

For moderate to severe IBS-Constipation. For patients who have not responded adequately to or cannot tolerate all other suitable treatment options BUT BEFORE other agents with higher costs.

Status: Amber Liothyronine tablets

ESCA in development

Status: Amber Lisdexamfetamine

ESCAs and additional advice in relation to age of patient and CCG

Status: Amber Lithium carbonate M/R tablet (Priadel)

Specialist initation only, ESCA

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top